Milpied N - Search Results

1

Prevention studies with pentoxifylline: new clinical projects.

Eugène-Jolchine I, Milpied N. Eugène-Jolchine I, et al. Among authors: milpied n. J Cardiovasc Pharmacol. 1995;25 Suppl 2:S143-6. doi: 10.1097/00005344-199500252-00030. J Cardiovasc Pharmacol. 1995. PMID: 8699855 Review.

2

Total body irradiation and high-dose cyclophosphamide, BCNU and VP-16 (CBV) as a new preparatory regimen for allogeneic bone marrow transplantation in patients with advanced hematologic malignancies.

Wu DP, Milpied N, Moreau P, Mechinaud-Lacroix F, Mahe B, Le Tortorec S, Rapp MJ, Bourdin S, Mahe JM, Harousseau JL. Wu DP, et al. Among authors: milpied n. Bone Marrow Transplant. 1994 Nov;14(5):751-7. Bone Marrow Transplant. 1994. PMID: 7889008

3

Placebo-controlled phase III trial of lenograstim in bone-marrow transplantation.

Gisselbrecht C, Prentice HG, Bacigalupo A, Biron P, Milpied N, Rubie H, Cunningham D, Legros M, Pico JL, Linch DC, et al. Gisselbrecht C, et al. Among authors: milpied n. Lancet. 1994 Mar 19;343(8899):696-700. doi: 10.1016/s0140-6736(94)91579-2. Lancet. 1994. PMID: 7510813 Clinical Trial.

4

[First-line treatment of severe myelomas of the young subject by high-dose melphalan].

Harousseau JL, Milpied N, Guilhot F, Garand R, Bourhis JH. Harousseau JL, et al. Among authors: milpied n. Presse Med. 1988 Aug 27-Sep 3;17(29):1471-4. Presse Med. 1988. PMID: 2971190 French.

5

Treatment of acute graft-versus-host disease with methylprednisolone and cyclosporine with or without an anti-interleukin-2 receptor monoclonal antibody. A multicenter phase III study.

Cahn JY, Bordigoni P, Tiberghien P, Milpied N, Brion A, Widjenes J, Lioure B, Michel G, Burdach S, Kolb HJ, et al. Cahn JY, et al. Among authors: milpied n. Transplantation. 1995 Nov 15;60(9):939-42. Transplantation. 1995. PMID: 7491697 Clinical Trial.

6

Autologous bone marrow transplantation vs intensive chemotherapy in first complete remission: interim results of GOELAM study in AML.

Harousseau JL, Pignon B, Dufour P, Ifrah N, Solary E, Abgrall JF, Milpied N, Desablens B, Guyotat D, Herve P. Harousseau JL, et al. Among authors: milpied n. Leukemia. 1992;6 Suppl 2:120-3. Leukemia. 1992. PMID: 1578912 Clinical Trial.

7

HLA-target antigens and T-cell receptor diversity of activated T cells invading the skin during acute graft-versus-host disease.

Gaschet J, Treviño MA, Cherel M, Vivien R, Garcia-Sahuquillo A, Hallet MM, Bonneville M, Harrousseau JL, Bragado R, Milpied N, Vié H. Gaschet J, et al. Among authors: milpied n. Blood. 1996 Mar 15;87(6):2345-53. Blood. 1996. PMID: 8630397 Free article.

8

Antineutrophil cytoplasmic antibodies (ANCA) in chronic graft-versus-host disease after allogeneic bone marrow transplantation.

Martin SJ, Audrain MA, Oksman F, Ecoiffier M, Attal M, Milpied N, Esnault VL. Martin SJ, et al. Among authors: milpied n. Bone Marrow Transplant. 1997 Jul;20(1):45-8. doi: 10.1038/sj.bmt.1700828. Bone Marrow Transplant. 1997. PMID: 9232255

9

Double-intensive therapy in high-risk multiple myeloma.

Harousseau JL, Milpied N, Laporte JP, Collombat P, Facon T, Tigaud JD, Casassus P, Guilhot F, Ifrah N, Gandhour C. Harousseau JL, et al. Among authors: milpied n. Blood. 1992 Jun 1;79(11):2827-33. Blood. 1992. PMID: 1350228 Free article.

10

Long-term results (12 years) of high-dose therapy in 127 patients with de novo multiple myeloma.

Moreau P, Misbahi R, Milpied N, Morineau N, Mahé B, Vigier M, Rapp MJ, Bataille R, Harousseau JL. Moreau P, et al. Among authors: milpied n. Leukemia. 2002 Sep;16(9):1838-43. doi: 10.1038/sj.leu.2402613. Leukemia. 2002. PMID: 12200701

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

451 results

Search Page

Filters